Crossref

1. Incidence of Cardiovascular Events After Renal Transplantation

- Emir Karaçağlar

- Arzu Neslihan Akgün

- İ. Haldun Müderrisoğlu

- Mehmet Haberal

2. Impact of the Number of Anti-Thrombosis Agents in Hemodialysis Patients: BOREAS-HD2 Study

- Marenao Tanaka

- Norihito Moniwa

- Hirofumi Ohnishi

- Tomohisa Yamashita

- Masayuki Koyama

- Yufu Gocho

- Keitaro Nishizawa

- Yukishige Kimura

- Hirohito Sugawara

- Sayaka Murakami

- Yusuke Okazaki

- Masato Furuhashi

- Hideaki Yoshida

- Tetsuji Miura

3. Renohepatic crosstalk: a review of the effects of acute kidney injury on the liver

- Anthony Bonavia

- Nicholas Stiles

4. A retrospective study of antithrombotic therapy use in an outpatient haemodialysis unit

- Kaye Dizon

- Patrick C. K. Ng

- Marisa Battistella

5. Efficacy and Safety of Ticagrelor Compared with Clopidogrel in Patients with End-Stage Renal Disease with Acute Myocardial Infarction

- Chien-Ho Lee

- Tzu-Hsien Tsai

- Cheng-Jui Lin

- Shu-kai Hsueh

- Wen-Jung Chung

- Cheng-I Cheng

6. Treatment of ischemic heart disease in end-stage kidney disease patients on renal replacement therapy

- Yu. V. Semenova

- B. L. Mironkov

- Ya. L. Poz

7.

8. High Risk Percutaneous Coronary Intervention of Left Main Bifurcation Stenosis in a Peritoneal Dialysis Patient

- Oliver Bushljetikj

- Biljana Zafirovska Taleska

- Zhan Zimbakov

- Frosina Arnaudova Dezulovic

- Irena Rambabova-Bushljetik

- Goce Spasovski

9. Hemodialysis exacerbates proteolytic imbalance and pro-fibrotic platelet dysfunction

- Aaron J. Velasquez-Mao

- Mark A. Velasquez

- Zhengxiong Hui

- Denise Armas-Ayon

- Jingshen Wang

- Moriel H. Vandsburger

10. Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndrome and on Dialysis: A Meta-Analysis

- Venkata Sai Harshabhargav Chenna

- Hemalatha Anam

- Majid Hassan

- Abdul Moeez

- Raja Reddy

- Sandipkumar S Chaudhari

- Koushik Sapkota

- Muhammad Usama

11. Antithrombotic therapy in end‐stage renal disease

- Svetha Chunduri

- Jon E. Folstad

- Tushar J. Vachharajani

12. Dual pathway inhibition in atherothrombosis prevention: yes, now we can!

- Francesco SUMMARIA

- Giuseppe BIONDI-ZOCCAI

- Enrico ROMAGNOLI

- Mamas A. MAMAS

- Francesco FRANCHI

- Paolo SEVERINO

- Carlo LAVALLE

- Francesco VERSACI

- Achille GASPARDONE

- Deepak L. BHATT

13. The New Kidney Donor Allocation System and Implications for Anesthesiologists

- Srikanth Sridhar

- Sara Guzman-Reyes

- Sam D. Gumbert

- Semhar J. Ghebremichael

- Angelina R. Edwards

- Mark J. Hobeika

- Wasim A. Dar

- Evan G. Pivalizza

14. Impact of hemodialysis on efficacies of the antiplatelet agents in coronary artery disease patients complicated with end-stage renal disease

- Zekang Ye

- Qin Wang

- Inam Ullah

- Qingxia Lin

- Tianyu Wu

- Mingwen Yang

- Yuansheng Fan

- Zhou Dong

- Tong Wang

- Jianzhen Teng

- Rui Hua

- Yingdan Tang

- Yule Li

- Xiaoxuan Gong

- Liang Yuan

- Zhengxian Tao

- Chunjian Li

15. Management of coronary artery disease and acute coronary syndrome in the chronic kidney disease population—A review of the current literature

- Justin M. Lingel

- Mukta C. Srivastava

- Anuj Gupta

16. Antiplatelet agents in hemodialysis

- Massimiliano Migliori

- Vincenzo Cantaluppi

- Alessia Scatena

- Vincenzo Panichi

17. Coronary Revascularization in Patients With Advanced Chronic Kidney Disease

- Pierluigi Costanzo

- Vladimír Džavík

18. Outcomes Following Percutaneous Coronary Intervention in Renal Transplant Recipients: A Binational Collaborative Analysis

- Muhammad Rashid

- Vinayak Nagaraja

- Ahmad Shoaib

- Nick Curzen

- Peter F. Ludman

- Samir R. Kapadia

- Nick Palmer

- Islam Y. Elgendy

- Ankur Kalra

- Tushar J. Vachharajani

- H. Vernon Anderson

- Chun Shing Kwok

- Mohamed Mohamed

- Adrian P. Banning

- Mamas A. Mamas